The F-BAR protein CIP4 in WAS-dependent thrombocytopenia
WAS依赖性血小板减少症中的F-BAR蛋白CIP4
基本信息
- 批准号:8202444
- 负责人:
- 金额:$ 24.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-08-20 至 2013-06-30
- 项目状态:已结题
- 来源:
- 关键词:ActinsAddressAffectAutoimmune DiseasesAutoimmune ProcessAutoimmunityB-LymphocytesBiologyBlood Platelet DisordersBlood PlateletsCardiovascular DiseasesCardiovascular systemCell membraneCell physiologyCytoskeletal ModelingCytoskeletal ProteinsDefectDiseaseDynaminEczemaFunctional disorderGenesGeneticGoalsHealthHemorrhageHumanImmuneImmunologic Deficiency SyndromesInflammationInflammatoryKnock-outKnockout MiceLabelLeadLinkLymphomaMeasuresMediatingMegakaryocytesMembraneMetabolic Clearance RateMicrotubulesMouse ProteinMouse StrainsMusMyelin P2 ProteinNatural Killer CellsNeoplasm MetastasisPathway interactionsPhenotypePhospholipidsPlayProductionProtein BindingProtein FamilyProteinsReportingRiskRoleSH3 DomainsScaffolding ProteinSignal PathwayStrokeT-LymphocyteTestingThrombocytopeniaVascular SystemWiskott-Aldrich SyndromeWorkYeastsbasecdc42 GTP-Binding Proteinimmune functionimprovedinsightmemberpolymerizationprotein functionrho GTP-Binding Proteinssrc-Family Kinasesyeast two hybrid system
项目摘要
DESCRIPTION (provided by applicant): Platelets play a central role in cardiovascular, stroke, and bleeding disease through their quantity, activation, and interaction with the inflammatory and vascular systems. The Wiskott -Aldrich syndrome (WAS) is an X- linked disorder characterized by thrombocytopenia, immunodeficiency, eczema and an increased risk of lymphoma and autoimmunity. The affected gene encodes the cytoskeletal protein, WASP. Through the RhoGTPase, Cdc42, WASp undergoes conformational change that leads to actin polymerization. How WASp results in thrombocytopenia, the most common manifestation of WAS, remains unknown. Cdc42, Src kinases, membrane phospholipids, and SH3 domains control WASP function. Our lab has discovered a new regulator of WASP, CIP4 (Cdc42 interacting protein 4), in a yeast two hybrid screen with the Src kinase Lyn as bait. CIP4 is a member of the F-BAR family of proteins, which remodel the plasma membrane and promote actin polymerization. To determine CIP4's function, we created a CIP4-null mouse. We found that CIP4-/- mice display thrombocytopenia, similar to that observed in WASP-/- mice. The mechanism for thrombocytopenia in WAS is not known. Some studies demonstrate an autoimmune basis; others a defect in proplatelet production. Because our mice do not display signs of autoimmune disease, we favor the hypothesis ("defective proplatelet formation hypothesis") that CIP4-WASP forms a signaling pathway that promotes platelet production and that a deficiency of either CIP4 or WASP perturbs actin polymerization in megakaryocytes, which results in defective proplatelet formation. An alternative "immune destruction hypothesis" states that a defect in this CIP4-WASP pathway promotes autoimmunity and immune-mediated destruction of platelets. We propose to address these hypotheses through the following two specific aims: 1) the defective proplatelet hypothesis by culturing megakaryocyte precursors and megakaryocytes from wild-type, CIP4-/-, WASP-/-, and CIP4-/-WASP-/- mice and analyzing their proplatelet formation. We will use these unique mice strains to analyze proplatelet formation, the interaction of CIP4 with microtubules in megakaryocytes, and ultrastructural features of platelets; and 2) Test the immune destruction hypothesis by labeling platelets and measuring their clearance rates in wild-type, CIP4-/-, WASP-/-, and CIP4-/-WASP-/- mice and measuring their T, B, and NK cell functions. We will use these unique mice strains to measure platelet survival and to correlate with altered immune function.
PUBLIC HEALTH RELEVANCE: Platelet production is critical for normal control of bleeding. Excessive bleeding and thrombocytopenia characterizes Wiskott - Aldrich syndrome (WAS). We have discovered a protein CIP4 that interacts physically and functionally with WAS Protein (WASP). The mechanism for the thrombocytopenia in WAS is not known. We will study platelet production in CIP4 knockout and CIP4/WASP double knockout mice to determine the precise mechanism that results in thrombocytopenia. Since platelets are involved in cardiovascular, stroke, and inflammatory diseases, our work has the potential to impact more broadly on human health.
描述(由申请方提供):血小板通过其数量、活化以及与炎症和血管系统的相互作用在心血管、中风和出血性疾病中发挥核心作用。Wiskott-Aldrich综合征(WAS)是一种X-连锁疾病,其特征是血小板减少症、免疫缺陷、湿疹和淋巴瘤和自身免疫风险增加。受影响的基因编码细胞骨架蛋白,WASP。通过RhoGTdR,Cdc 42,WASp经历构象变化,导致肌动蛋白聚合。WASp如何导致血小板减少症(WAS最常见的表现)仍然未知。Cdc 42、Src激酶、膜磷脂和SH 3结构域控制WASP功能。本实验室以Src激酶林恩为诱饵,在酵母双杂交筛选中发现了一种新的WASP调节因子CIP 4(Cdc 42 interacting protein 4)。CIP 4是F-BAR蛋白家族的成员,其重塑质膜并促进肌动蛋白聚合。为了确定CIP 4的功能,我们创建了CIP 4-null小鼠。我们发现,CIP 4-/-小鼠显示血小板减少症,类似于在WASP-/-小鼠中观察到的。WAS中血小板减少症的机制尚不清楚。一些研究证明了自身免疫的基础;其他人在前血小板生产的缺陷。因为我们的小鼠没有显示出自身免疫性疾病的迹象,所以我们倾向于CIP 4-WASP形成促进血小板产生的信号传导途径并且CIP 4或WASP的缺乏扰乱巨核细胞中的肌动蛋白聚合的假说(“缺陷性前血小板形成假说”),这导致缺陷性前血小板形成。另一种“免疫破坏假说”指出,该CIP 4-WASP途径中的缺陷促进自身免疫和免疫介导的血小板破坏。我们提出通过以下两个具体目标来解决这些假设:1)通过培养来自野生型、CIP 4-/-、WASP-/-和CIP 4-/-WASP-/-小鼠的巨核细胞前体和巨核细胞并分析它们的前血小板形成来解决有缺陷的前血小板假设。我们将使用这些独特的小鼠品系来分析前血小板形成、CIP 4与巨核细胞中微管的相互作用以及血小板的超微结构特征;以及2)通过标记血小板并测量它们在野生型、CIP 4-/-、WASP-/-和CIP 4-/-WASP-/-小鼠中的清除率以及测量它们的T、B和NK细胞功能来测试免疫破坏假说。我们将使用这些独特的小鼠品系来测量血小板存活率,并与免疫功能的改变相关联。
公共卫生相关性:血小板生成对于正常控制出血至关重要。出血过多和血小板减少是Wiskott-Aldrich综合征(WAS)的特征.我们发现了一种蛋白质CIP 4,它在物理和功能上与WAS蛋白(WASP)相互作用。WAS中血小板减少症的机制尚不清楚。我们将研究CIP 4基因敲除和CIP 4/WASP双基因敲除小鼠的血小板生成,以确定导致血小板减少症的确切机制。由于血小板与心血管、中风和炎症性疾病有关,我们的工作有可能对人类健康产生更广泛的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Seth Joel Corey其他文献
Seth Joel Corey的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Seth Joel Corey', 18)}}的其他基金
Genetic Dissection of Stress Responses in Shwachman-Diamond Syndrome
什瓦赫曼-戴蒙德综合征应激反应的基因剖析
- 批准号:
10594366 - 财政年份:2023
- 资助金额:
$ 24.91万 - 项目类别:
Multiscale Modeling of Myelodysplastic Syndromes
骨髓增生异常综合征的多尺度建模
- 批准号:
8927960 - 财政年份:2015
- 资助金额:
$ 24.91万 - 项目类别:
Multiscale Modeling of Myelodysplastic Syndromes
骨髓增生异常综合征的多尺度建模
- 批准号:
9323833 - 财政年份:2015
- 资助金额:
$ 24.91万 - 项目类别:
Multiscale Modeling of Myelodysplastic Syndromes
骨髓增生异常综合征的多尺度建模
- 批准号:
9144830 - 财政年份:2015
- 资助金额:
$ 24.91万 - 项目类别:
Genetic Modifiers for Cancer Stem Cells in Secondary MDS/AML
继发性 MDS/AML 中癌症干细胞的基因修饰
- 批准号:
8644088 - 财政年份:2014
- 资助金额:
$ 24.91万 - 项目类别:
Genetic Modifiers for Cancer Stem Cells in Secondary MDS/AML
继发性 MDS/AML 中癌症干细胞的基因修饰
- 批准号:
8787717 - 财政年份:2014
- 资助金额:
$ 24.91万 - 项目类别:
The F-BAR protein CIP4 in WAS-dependent thrombocytopenia
WAS依赖性血小板减少症中的F-BAR蛋白CIP4
- 批准号:
8322103 - 财政年份:2011
- 资助金额:
$ 24.91万 - 项目类别:
Targeted Therapy of Lyn in Myelodysplastic Syndrome
Lyn 治疗骨髓增生异常综合征的靶向治疗
- 批准号:
7680896 - 财政年份:2006
- 资助金额:
$ 24.91万 - 项目类别:
Targeted Therapy of Lyn in Myelodysplastic Syndrome
Lyn 治疗骨髓增生异常综合征的靶向治疗
- 批准号:
7190561 - 财政年份:2006
- 资助金额:
$ 24.91万 - 项目类别:
Targeted Therapy of Lyn in Myelodysplastic Syndrome
Lyn 治疗骨髓增生异常综合征的靶向治疗
- 批准号:
7034786 - 财政年份:2006
- 资助金额:
$ 24.91万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 24.91万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 24.91万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 24.91万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 24.91万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 24.91万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 24.91万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 24.91万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 24.91万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 24.91万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 24.91万 - 项目类别:
Research Grant